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Critical care delivery is a complex, expensive, error prone, medical specialty and remains the focal point of major
improvement efforts in healthcare delivery. Various modeling and simulation techniques offer unique opportunities
to better understand the interactions between clinical physiology and care delivery. The novel insights gained from
the systems perspective can then be used to develop and test new treatment strategies and make critical care
delivery more efficient and effective. However, modeling and simulation applications in critical care remain
underutilized. This article provides an overview of major computer-based simulation techniques as applied to
critical care medicine. We provide three application examples of different simulation techniques, including a)
pathophysiological model of acute lung injury, b) process modeling of critical care delivery, and c) an agent-based
model to study interaction between pathophysiology and healthcare delivery. Finally, we identify certain challenges
to, and opportunities for, future research in the area.Review
Introduction
Modeling and Simulation (M&S) has been commonly
used in various scientific domains including ecology, so-
cial sciences, economics, and engineering [1]. Modeling
has been used by healthcare professionals to investigate
disease mechanisms and design novel pharmaceutical
agents. In industry sectors, such as manufacturing, avi-
ation, and logistics, M&S techniques have led to major
improvements in decision making, efficiency, and quality
[2-5]. A real system is modeled to understand its behav-
ior [1]. After building a model from observation or
knowledge of a real system, we then test it—a process
that is known as simulation. Simulations allow for test-
ing different scenarios, and their results provide explana-
tions for the behavior of the real system and can
evaluate various strategies for effective and efficient sys-
tem operation. The simulation results often indicate the
quality of the model itself and may give insight for how
to improve its accuracy. A model may be used to high-
light areas of system deficiency and predict the impact* Correspondence: gajic.ognjen@mayo.edu
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normal functioning of a complex system.
Novel medical applications of M&S include studying
disease and physiologic processes, predicting and examin-
ing human performance, and conducting system evalua-
tions in complex, high-risk healthcare environments [6].
Simulation also has contributed significantly to better
training and assessment of clinical and procedural skills;
however, this has been extensively reviewed and is not the
focus our discussion [7,8]. In this review, we summarize
current developments of computer-based M&S applica-
tions as they may apply to critical care medicine.Rationale for using systems modeling and simulation to
improve critical care outcomes
Sir Cyril Chantler stated that “Medicine used to be sim-
ple, ineffective and relatively safe. Now it is complex, ef-
fective and potentially dangerous” [9]. The intensive care
unit (ICU) is an extremely diverse environment with
multidisciplinary, multispecialty team members provid-
ing care to critically ill patients with complex diseases,
using advanced treatment options and technology, under
the constraints of physical and electronic infrastructure,
equipment, supplies, and processes. All of these ele-
ments increase the risk of error and potential threat to
patient safety in the ICU [10-13].Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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inantly attributed to the patient’s genetic predisposition,
baseline dysfunction, and severity of insult. Data have
shed light on the importance of an additional factor:
faulty healthcare delivery. Epidemiologic data suggests
that delayed or overly aggressive treatments and
iatrogenic complications are among the most important
drivers of multiorgan failure and poor outcomes during
critical illness [14,15].
The ICU is a typical example of a complex adaptive
system where collections of interacting components
(genome, cells, organ systems, patient, family member,
providers, hospitals) react to environments and other
agents across different hierarchical levels (Figure 1) [16].
Investigating the relationship between specific exposures
and outcomes of critical care medicine is challenging
due to complex interactions between patient physiology,
psychosocial status, and the corresponding healthcare
delivery. Different systems’ components interact across
varying time scales (seconds to decades) and different
spatial scales (from molecular biology to national health-
care policy) within the constraints of physical and cul-
tural environments. The inferences from conventional
experimental reductionist and heuristic approaches are
limited and even impractical; therefore, novel holistic
systems-based approaches are clearly needed. It has been
increasingly recognized that the application of simula-
tion methods can offer a novel approach to address the
current multifaceted challenges confronting healthcare
[5].Figure 1 Network medicine approach, adapted from Barabasi et al. [1
intravascular coagulation.Grimm and colleagues provide an outstanding review
of modeling approaches for complex- systems analysis
[17]. One of the key premises in complex-systems
analysis is that knowledge of the elements (agents) that
make up a complex system is necessary, but by no
means sufficient to understand systems behavior and its
impact on (clinical) outcomes. Identifying and decipher-
ing the rules of association and integration within a
system are needed if significant breakthroughs in critical
care medicine are to occur [18,19]. Researchers collect
relevant information about elements at different resolu-
tions, formulate theories about their behavior, imple-
ment these theories in a computer model, and, through
simulation, observe the emergence of system-level prop-
erties related to particular hypotheses. Multiple patterns
observed in real systems at different hierarchical levels
and scales are used to optimize systematically model
complexity and reduce uncertainty.
The availability of quantitative data and the short
course from the onset of critical illness to outcome
(~60 days) are the clear advantages of implementing
M&S methodology to critical care medicine, because it
allows for ready validation of hypotheses. Rapid
turnaround from the onset of critical illness to outcome
and an extremely data-rich environment make the ICU a
superb setting in which to explore and develop the
capabilities for applying M&S methodologies. One of the
first applications of such an approach could be to
improve the design and conduct of critical care clinical
trials. Currently, nearly all clinical trials in critical care6]. AKI, acute kidney injury; ALI, acute lung injury; DIC, disseminated
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systematic review of randomized trials in critical care by
Vincent, due to either naive hypotheses or lack of
systems understanding of critical illness and care
delivery [20].
Modeling and Simulation can enhance the views of
clinical researchers by providing better-suited, more
precise hypotheses to be tested in future experiments. In
fact, preliminary studies by researchers at the University
of Pittsburgh suggest that “in silico” modeling could
have prevented universally disappointing results of antic-
ytokine trials in patients with sepsis by pointing out the
critical importance of timing of experimental interven-
tion in relation to infectious insult [21]. Similarly, both
the timing of interventions tested in current animal
models and the lack of appreciation of multiple covari-
ates (multiple hits) in clinical practice preclude the
meaningful progress of translational research in acute
lung injury (ALI). M&S can provide an invaluable
platform for 1) designing clinical experiments, 2) process
improvement of care delivery, 3) forecasting and deci-
sion support at the patient’s bedside, and 4) informing
healthcare policy decisions.
Because a detailed discussion of M&S tools is beyond
the objective of this paper, we will instead focus on 1)
M&S objective metrics, approaches, and tools, and 2)
examples of M&S applications used to study interactions
among system components (disease syndromes, patients,
providers, and processes) in critical care.
Common modeling and simulation applications in critical
care
Thanks to the continual advancement of computer and
information technologies, success of advanced engineer-
ing methodologies and increased electronic medical rec-
ord adoption, healthcare sectors are increasingly
interested in unleashing the full potential of M&S. The
taxonomy of modeling approaches is wide, and the type
of modeling approach one chooses to employ depends
largely on which component of information about the
healthcare delivery system is available (patients, provi-
ders, hospitals), its form and fidelity. The upper half of
Figure 2 displays the three major classes of model types,
available information types, as well as model expectation
categories. The lower part of Figure 2 shows how the ex-
pectation from the model to be built, along with which
information is available, allows for the selection of the
model type. For instance, a certain patient’s disease pre-
diction in time is sought. The available information
includes clinical rules, logic flow of disease progression
in time, as well as a live stream of numerical ICU data at
a certain frequency. Given this set of data, a possible
modeling approach would be a hybrid combination of
discrete dynamic equations along with an inferenceengine, working with a real-time parameter estimation
scheme. The different model types refer to different
mathematical classes of representation. A modeling
approach involves a model type along with accompany-
ing mathematical methods in order to render, for
instance, a generic mathematical model fine-tuned to an
individual patient.
M&S applications can then provide systems- or data-
based decision support that would lead to defining a
new therapeutic target, predicting patient’s health status
or conducting system evaluations of ICU workflow.
M&S also offers several distinct gains in learning oppor-
tunities that cannot be achieved by traditional
approaches [22,23].
Monte Carlo simulation & Markov simulation
Monte Carlo simulation (MCS) is a commonly used
method for modeling complex systems having recursive
processes and events that are impractical and time-
consuming to test in the physical world. It generates
numerous output scenarios by repeatedly picking
random samples from an uncertain variable based on
probability distribution. For instance, this mathematical
tool has been used in large-cohort studies to assess
whether regionalized intensive care could improve the
outcome of patients who require mechanical ventilation
[24]. Simulation of time-dependent probabilities of bac-
terial spread offered new means for testing various inter-
vention strategies (antibiotics and infection control) in
critical care practices [25]. MCS has been used with
optimization techniques to enhance clinical decision
making by maximizing antibiotics dosing [26,27].
Markov simulation is another random-process modeling
tool that often is used for economic evaluations when
comparing different outcomes of complex medical inter-
ventions [28]. It has been used to investigate ICU clinical
decision making by revealing evidence for sex-based risk
difference in ICU patients [29]. Critical care applications
of these tools have been recently reviewed by Kreke
et al. [30].
Discrete event simulation
Discrete event simulation (DES) is among the most
commonly applied stochastic analysis tools. DES pro-
vides the user with a “test-bed” to perform experiments
via computer modeling and test the likely effectiveness
of different solutions before their implementation.
Different “what-if” scenarios can then be performed in a
“prototype” testing environment. A key aspect of DES is
the system-state description, which includes values for
variables of the system components: probability distribu-
tion of entity arrival, event duration, event status, and
resources needed. It provides a novel process evaluation
mechanism grounded in scientific principles for
Figure 2 Elements for modeling approach selection.
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drills, and workflow redesign. DES has been used in the
healthcare industry to support clinical decision making,
facility planning (to predict bed occupancy), resource al-
location (staffing), treatment evaluation, emergency
room organizational redesign, and ICU information sys-
tem usability tests [31-36]. Such applications demon-
strate that M&S could be a key enabler for realizing
transformation in complex healthcare delivery systems.
System dynamics
System dynamics (SD) is a computer-based approach for
performing policy evaluation and decision making in
systems, such as ecological settings and business pro-
cesses that exhibit dynamic complexity [37]. The charac-
teristics and behaviors of systems that exhibit dynamic
complexity are typically governed by a large number of
factors. For example, dynamic systems may exhibit
different change in their structure or behavior over vary-
ing time scales. Similarly, degree of connectedness, non-
linearity, degree of adaptiveness, self-organizing
behavior, complexity of feedback structure, and systems
dependence on historical states are just some of the fac-
tors that generate dynamic complexity within a system
[38]. SD is centered on feedback control theory that uses
causal a feedback loop mechanism (that describes the re-
lationship between stocks and flows) to describe either
mathematically or graphically endogenous changes that
occur within a system. The combination of both qualita-
tive and quantitative approaches makes SD useful at the
strategic level [39]. The capacity to describe systems thatchange over time and generate feedback is central to
advanced engineering methodologies and is applied ubi-
quitously across industrial fields. It also has been used
extensively to perform macro-level policy analysis, such
as in the area of public health and health policy [40].
The application of SD in critical care remains underuti-
lized and should be further investigated.
Agent-based simulation
Agent-based simulation (ABS) is a stochastic simulation
in which the local interactions of collections of individ-
ual decision-making entities (agents), following simple
rules, result in complicated and often nonobvious pat-
terns at the aggregate level [41]. The technique has been
used extensively for simulating complex adaptive sys-
tems (CAS) in ecology and social sciences [17]. An ABS,
when coupled with a robust data resource that provides
detailed and reliable essential data elements (patient,
provider, and setting characteristics from onset of acute
illness through outcome), makes it possible to model
critical diseases in a bottom-up manner. Instead of
building a single regression model to predict the entire
range of behaviors in one simplified relationship, ABS
seeks to capture emergent phenomena from individual
agents. It represents low-level individual behaviors from
different scales (e.g., organ system, hospital) that to-
gether result in the observed high-level patterns—with
multiple dimensions [41]. Simply put, traditional model-
ing describes the forest as an indivisible entity, whereas
CAS modeling describes the trees and allows the con-
cept of a forest to emerge as a consequence.
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The complexity of the disease, insufficient understanding
of the evolution and progress of risk factors, and numer-
ous other modifiers severely limit the capabilities of clin-
icians and researchers to predict disease development
and progression and to define appropriate therapeutic
targets. In addition to clinical knowledge-based rules,
variables, such as genome, disease burden, physiological
parameters and conditions, and clinical research evi-
dence, provide conditional probability distributions for
modeling logic outputs from organ status to clinical syn-
dromes and outcomes. Due to the complexity of human
biology, a bottom-up integrative approach combining
data from different levels (genes, molecules, cells,
organs, body, etc.) is of limited help in understanding
disease pathophysiology [42]. Such approaches are based
on mathematical models of disease development. These
models can serve many purposes, such as understanding
disease mechanisms, disease detection, disease predic-
tion, and in silico testing of “what-if” scenarios and even
clinical trials. As such, these models also can be used in
clinical decision-support systems.
Archimedes (Archimedes, Inc., San Francisco, CA), for
example, is a mathematical model that represents the
anatomy, physiology, and pathology pertinent to diabetes
and its complications [43]. This model has beenFigure 3 Acute lung injury detection model architecture.extensively validated and has already found multiple
applications in healthcare policy and research [43,44].
Recently, chronic obstructive pulmonary disease (COPD)
models have been developed to offer multilevel
approaches to investigate COPD complexity [45]. A new
model [46] that was recently developed for ALI detec-
tion uses three information sources: electronic medical
record (EMR) data, published epidemiologic studies, and
mechanistic understanding of domain experts (Figure 3).
Three modeling techniques were combined: rule-based
fuzzy inference, state flow diagrams, and data-based cor-
relation using Bayesian Networks. Clinical ALI develop-
ment knowledge from ICU physicians were articulated
verbally and subsequently written mathematically in
terms of linguistic variables and rules. This method leads
to a crisp value ALI detection score.
Published research articles from clinical trials report-
ing odds ratios and confidence intervals were subse-
quently translated into probability distributions and
conditional probability tables feeding a Bayesian
Network. This method generates probabilistic a priori
knowledge about forward-computing the probability of
an event occurring. Finally, pathophysiological under-
standings of disease mechanisms were translated into
event-based conditional rules. A Finite-State Machine
(FSM) was then used, because it represents transition
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event trigger. Different states become active as FSM
matures with more data records provided as inputs over
time. The last state in the FSM logical flow path is indi-
cative of respiratory failure and ultimately of ALI onset.
This type of approach is not data-based, because no data
mining or statistical correlations were employed. ICU
and pre-ICU data was fed into the developed model to
generate ALI detection scores [46]. Other studies also
demonstrate the potential of using this approach to ad-
dress acute inflammatory response and sepsis progres-
sion in critical care [47-49].Modeling care process for better healthcare delivery
ICU system operations are centered on critically ill
patients admitted to units from the emergency room or
floor. The ICU interacts with various parts of the hos-
pital system, such as laboratory, transfusion, surgery,
interventional and diagnostic radiology services, etc. A
lack of clear understanding of critical issues such as
workflow variation, resource constraints, communica-
tion, etc., precludes us from developing a meaningful
understanding of latent factors that cause the sub-
optimal performance of an ICU. The concept of systems
understanding of care delivery was first introduced by
Donabedian, but has been more recently championed by
numerous advocates including patient groups, providers
and business experts [50-53]. Using multifaceted systems
engineering approaches, key ICU processes (admission,
resuscitation, rounding, handoff, etc) can be modeled to
analyze and modify healthcare delivery in an ICU
setting. (Figure 4)
The process model can be used for several purposes,
such as describing the flow of patients admitted to an
ICU or predicting the future state of a patient condi-
tional upon the complex interactions of several activities
and decisions made in the prior state. Each phase
requires an elaborate and in-depth multiscale study of
key ICU processes. For example, using a process-
modeling approach, a prototype of a DES model of sep-
tic shock resuscitation has been developed recentlyFigure 4 The schematic representation of care process in ICU.(Figure 5) [54]. This model is based on data collected
through field observations, electronic medical records,
and healthcare provider estimations. Options for
improvements in system performance and workflow re-
design were then implemented and tested by using a
computer simulation model specific to sepsis resuscita-
tion. Several key interventions could be investigated
without patient harm: reduction of central line proced-
ure time, modification of laboratory sample draws, etc.
The model aims to refine, verify, and validate a compre-
hensive resuscitation process. This approach also is ap-
plicable to other critical care emergencies, including
massive bleeding (hemorrhagic shock) or increased
intracranial pressure.Agent Based Simulation to study the interaction between
pathophysiology and healthcare delivery (“nature” and
“nurture”)
Because of the robust data set from the EMR and vari-
ous other information sources existing in the modern
critical care environment, it is possible to conduct simu-
lations that will produce verifiable streams of data. At
the same time, those simulation exercises also can yield
additional variables and insights that are not explicitly
represented in the data streams. For example, one may
detect patterns of disease progression and health thresh-
olds (at the individual patient level), as well as poten-
tially unforeseen consequences of decisions made at the
clinical care level in the ICU. Other relationships and
system component attributes are then hypothesized,
realizing a wider range of possible influences and feed-
back mechanisms that could account for nonlinear dy-
namics (for example, a threshold for development of
MODS [multiple organ dysfunction syndrome]). “Na-
ture” refer to pathogenesis of acute lung injury.
“Nurture” refers to care processes that may be as im-
portant as the individual’s biology in development of
ALI and MODS (Figure 6).
Within an individual patient, for example, there are
multiple organ systems that follow physiological rules













Figure 5 Model of sepsis resuscitation process in ICU.
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also engages in a clinical setting consisting of providers
and patients that interact as part of treatment, producing
a second layer of aggregate (population health and
outcome) results. The outcomes of a simulation at one
level can both constrain and direct simulations at other
levels.
Still more real-time data elements can be added to the
model as (hypothetical) aggravating or mitigating effects
toward specific organ function, improved process effi-
ciency, or overall patient-centered outcomes. During theFigure 6 Schematic representation of multiscale modeling approachcourse of many simulation runs, the attributes and com-
ponent relationships that best fit the patient data begin
to emerge, allowing for closer approximations of which
factors are relevant to patient-centered outcomes and
revealing their degree of importance. The inconsequen-
tial factors can be eliminated as unnecessary complica-
tions to the model. However, by using the complex
adaptive systems architecture to simulate these relation-
ships, it is not necessary to be able to predict precisely
what these casual connections are a priori. By allowing
the system to hypothesize the various directions andto simulate acute lung injury and its consequences.
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calibrating across the time-series data as new patient
populations enter the stream, with some segment of that
data set aside for testing to guard against overfitting of
the data. Once a rigorous general model has been built
and tested, then patient-specific data can be input in
real-time, which will, ideally, allow the simulation to
identify likely outcomes and flag potentially adverse con-
sequences before they occur. For example, to further in-
vestigate the host response and complex interactions
among cells, cellular networks and organs—as well as to
develop treatment options for multifactorial critical ill-
nesses, various M&S applications (including a hybrid ap-
proach) have been explored [21,55-57]. ABS methods
also have been used for in silico clinical trials to study
systemic inflammatory response syndrome/multiple
organ failure/acute respiratory distress syndrome using a
system-biology approach [58-60].
Challenges and future recommendations
Several barriers have been identified that have prevented
widespread use and adoption of modeling and simula-
tion in healthcare [5,23,61,62]. For example, there are
significant disconnects between modeling professionals
and healthcare providers, preventing the implementation
of proposed models. Furthermore, complexity of both
illness and corresponding medical practice, provider-
centered rather than patient-centered care, system frag-
mentation, lack of resources, and limited accuracy and
availability of key data elements all hinder rapid applica-
tion of M&S techniques in critical care and other areas
of acute medicine. In addition to multiple layers pertin-
ent to critical illness (from cell metabolism and systems
biology to clinical physiology), researchers and policy
makers need to consider both “sharp end” (provider
education, etc.) and “blunt end” (organizational
optimization, etc.) layers of the healthcare delivery sys-
tem [63,64]. The adoption of the EMR has made patient
data (labs, vital signs, notes, etc.) more readily available
and will no doubt enhance future modeling approaches
(with the addition of large data sets for data mining and
predictive modeling) [65]. Further EMR improvements
will result in even more meaningful data from various
system components of care delivery, such as ICU oper-
ational data, provider performance and related process
data, as well as more precise account of meaningful pa-
tient outcomes (functional status, quality of life, family
satisfaction). These are typically stored across several
system components but can be collected and analyzed
for optimizing disease management [66].
Conclusions
The National Academy of Engineering and the Insti-
tute of Medicine of the National Academies directedattention to the issue of systems engineering, model-
ing, and simulation application in medicine with their
joint report in 2005: “Building a Better Delivery Sys-
tem: A New Engineering/Health Care Partnership”
[67]. Recently, the American Medical Association
(AMA) and the Institute for Electronic and Electrical
Engineers (IEEE) Engineering in Medicine and Biology
Society have joined hands for a Second Annual AMA-
IEEE Medical Technology Conference in 2011. The
unique collaboration between experts in critical care
medicine, engineering, research, education, and med-
ical informatics promises to provide clinically relevant
systematic approaches and comprehensive solutions to
many of the challenging problems in clinical medicine
[68]. The M&S-based systematic analysis of both clin-
ical pathophysiology and healthcare delivery will allow
for testing of specific interventions (from virtual clin-
ical trials to quality improvement) before clinical de-
ployment, effectively forecasting patient health in the
ICU and eliminating potential patient harm. This cap-
acity will offer possibilities to better select high-
impact and low-cost interventions for the consider-
ation of future critical care research and quality
improvement.
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